Katy Beckermann: Feasibility of an intermittent ipi/nivo approach in their Phase II trial

Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X:

“Congrats to Moshe Ornstein, MD and team for demonstrating the feasibility of an intermittent ipi/nivo approach in their Phase II trial, showing potential for prolonged treatment-free intervals.  Looking forward to more studies like this.”